2159-0325 Screening compound: (2E)-N-(diphenylmethyl)-3-(4-methoxyphenyl)prop-2-enamide

2159-0325 Screening compound: (2E)-N-(diphenylmethyl)-3-(4-methoxyphenyl)prop-2-enamide
2159-0325 Screening compound: (2E)-N-(diphenylmethyl)-3-(4-methoxyphenyl)prop-2-enamide alternative view

Chemical Structure Depiction of ChemDiv screening compound 2159-0325
(2E)-N-(diphenylmethyl)-3-(4-methoxyphenyl)prop-2-enamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

2159-0325

Molecular Formula

C23H21NO2 (C23 H21 NO2)

Compound Name

(2E)-N-(diphenylmethyl)-3-(4-methoxyphenyl)prop-2-enamide

IUPAC name

(2E)-N-(diphenylmethyl)-3-(4-methoxyphenyl)prop-2-enamide

SMILES

COc1ccc(/C=C/C(NC(c2ccccc2)c2ccccc2)=O)cc1

InChI

InChI=1S/C23H21NO2/c1-26-21-15-12-18(13-16-21)14-17-22(25)24-23(19-8-4-2-5-9-19)20-10-6-3-7-11-20/h2-17,23H,1H3,(H,24,25)

InChI Key

ASRPDYUBNFCGGI-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD01129302

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

343.43

Hydrogen Bond Acceptors Count

3.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

3

Partition Coefficient, logP

4.818

Distribution Coefficient, logD

4.818

Water Solubility, LogSw

-4.62

Polar Surface Area

31.063

Acid Dissociation Constant (pKa)

11.03

Base Dissociation Constant (pKb)

-0.83

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

8.70

2159-0325 in Drug Discovery

Included in Screening Libraries

DGK Inhibitors Library (10558 compounds)

Glucocorticoid receptors Library (4806 compounds)

Covalent Inhibitors Library (7986 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Congenital
  • Metabolic
  • Endocrine
Targets:
  • Kinases
  • Nuclear receptors
Mechanism of action:
  • Receptor's ligands
Structure:
  • Cyclic compounds
  • 3D
  • Fragments

References: we are preparing a list of scientific research reports with 2159-0325 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 2159-0325?
Check Price and Availability of 2159-0325, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 2159-0325 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 2159-0325
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 2159-0325
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 2159-0325 available by request